Status:

TERMINATED

Performance of Diuretic Stress Test in Predicting Short Term Renal Recovery in Oliguric Critically-ill Patients Recovery in the Short Term

Lead Sponsor:

Centre Hospitalier Universitaire de Saint Etienne

Conditions:

Critical Illness

Oliguria

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Acute kidney injury (AKI) is a common disorder and associated with high morbidity and mortality. However, distinguishing transient AKI from persistent AKI may help in individualizing treatment and lim...

Eligibility Criteria

Inclusion

  • Adult patients (age \> 18 y.o)
  • AKI stage 1 or more according to KDIGO
  • Oliguria as defined by an oliguria lower than 0.5 mL/Kg
  • Affiliation to the National Medical Insurance

Exclusion

  • Pregnancy
  • Chronic kidney disease stage 4 or more
  • Need for fluid bolus (\>1000 mL crystalloids or equivalent) or need for vasopressors increases or introduction in the 2 hours preceding inclusion
  • Evidence of obstructive renal failure

Key Trial Info

Start Date :

April 11 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 21 2018

Estimated Enrollment :

93 Patients enrolled

Trial Details

Trial ID

NCT02800135

Start Date

April 11 2016

End Date

March 21 2018

Last Update

June 14 2019

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

CHU de CLERMONT-FERRAND

Clermont-Ferrand, France, 63000

2

CHU de MONTPELLIER

Montpellier, France, 34000

3

CHU de SAINT-ETIENNE

Saint-Etienne, France, 42000

4

CHRU de STRASBOURG

Strasbourg, France, 67000